IHE · iShares U.S. Pharmaceuticals ETF
United States · RS rating 79 · As of 2026-10-14
| Price | 99.49 USD |
|---|---|
| 1-day change | +2.2% |
| RS rating (overall / 1M / 3M / 12M) | 79 / 57 / 61 / 85 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 34 / 65 / 22 |
| Industry group (rank) | Finance-ETF / ETN (48) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +8.0% |
| Market cap (USD) | – |